Roderic G Eckenhoff, MD uses innovative chemical biological tools to reveal new anesthetic targets, and mechanisms of their modulation and contribution to the complex state of anesthesia.
Victoria M. Bedell, MD, PhD uses the zebrafish model to study the mechanisms of anesthesia and sedation.
Thomas T. Joseph, MD, PhD uses computational biophysics and molecular dynamics simulation to study anesthetic mechanisms.
Max B Kelz, MD, PhD uses advanced ex vivo and in vivo approaches to study cellular and network interactions that underlie both the anesthetic state, and the transitions between states of anesthesia and wakefulness.
Renyu Liu, MD, PhD is interested primarily in the molecular pharmacology of opioids, specifically kappa agonists, and their potential use for neuroprotection.
Andrew McKinstry-Wu, MD uses sophisticated optical and chemical approaches to reveal the mechanisms by which alpha-2 agonists produce sedation.
Alex Proekt, MD, PhD uses electrophysiology and advanced statistical approaches to understand how the brain “reboots” during emergence from anesthesia.